Click for best price
Head Neck Cancer Therapeutics Market Size, Share 2022
Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.
Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market.
This report contains market size and forecasts of Head and Neck Cancer Therapeutics in Global, including the following market information:
Global Head and Neck Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Head and Neck Cancer Therapeutics market was valued at 1064.2 million in 2021 and is projected to reach US$ 1703 million by 2028, at a CAGR of 6.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Head and Neck Cancer Therapeutics include Sanofi, Eli Lilly, Amgen, Actavis, Dr. Reddy?s Laboratories, Jiangsu Hengrui, Teva Pharmaceutical, DFG and BioXpress. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Head and Neck Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Head and Neck Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Head and Neck Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
PD Inhibitors
Microtubule Inhibitors
EGFR Inhibitors
Global Head and Neck Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Head and Neck Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Surgery
Radiation therapy
Chemotherapy
Immunotherapy
Global Head and Neck Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Head and Neck Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Head and Neck Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Head and Neck Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy?s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress
| Report Attributes |
Report Details |
| Report Title |
Head and Neck Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Head and Neck Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Head and Neck Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Head and Neck Cancer Therapeutics Overall Market Size
2.1 Global Head and Neck Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Head and Neck Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Head and Neck Cancer Therapeutics Players in Global Market
3.2 Top Global Head and Neck Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Head and Neck Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Head and Neck Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Head and Neck Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Head and Neck Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Head and Neck Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Head and Neck Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Head and Neck Cancer Therapeutics Market Size Markets, 2021 & 2028
4.1.2 PD Inhibitors
4.1.3 Microtubule Inhibitors
4.1.4 EGFR Inhibitors
4.2 By Type - Global Head and Neck Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Head and Neck Cancer Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Head and Neck Cancer Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Head and Neck Cancer Therapeutics Market Size, 2021 & 2028
5.1.2 Surgery
5.1.3 Radiation therapy
5.1.4 Chemotherapy
5.1.5 Immunotherapy
5.2 By Application - Global Head and Neck Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Head and Neck Cancer Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Head and Neck Cancer Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Head and Neck Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Head and Neck Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Head and Neck Cancer Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Head and Neck Cancer Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Head and Neck Cancer Therapeutics Revenue, 2017-2028
6.3.2 US Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.3.3 Canada Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.3.4 Mexico Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Head and Neck Cancer Therapeutics Revenue, 2017-2028
6.4.2 Germany Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.4.3 France Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.4.4 U.K. Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.4.5 Italy Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.4.6 Russia Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.4.8 Benelux Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Head and Neck Cancer Therapeutics Revenue, 2017-2028
6.5.2 China Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.5.3 Japan Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.5.4 South Korea Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.5.6 India Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Head and Neck Cancer Therapeutics Revenue, 2017-2028
6.6.2 Brazil Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.6.3 Argentina Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Head and Neck Cancer Therapeutics Revenue, 2017-2028
6.7.2 Turkey Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.7.3 Israel Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Head and Neck Cancer Therapeutics Market Size, 2017-2028
6.7.5 UAE Head and Neck Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Head and Neck Cancer Therapeutics Major Product Offerings
7.1.4 Sanofi Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Sanofi Key News
7.2 Eli Lilly
7.2.1 Eli Lilly Corporate Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Head and Neck Cancer Therapeutics Major Product Offerings
7.2.4 Eli Lilly Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Eli Lilly Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Head and Neck Cancer Therapeutics Major Product Offerings
7.3.4 Amgen Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Amgen Key News
7.4 Actavis
7.4.1 Actavis Corporate Summary
7.4.2 Actavis Business Overview
7.4.3 Actavis Head and Neck Cancer Therapeutics Major Product Offerings
7.4.4 Actavis Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Actavis Key News
7.5 Dr. Reddy?s Laboratories
7.5.1 Dr. Reddy?s Laboratories Corporate Summary
7.5.2 Dr. Reddy?s Laboratories Business Overview
7.5.3 Dr. Reddy?s Laboratories Head and Neck Cancer Therapeutics Major Product Offerings
7.5.4 Dr. Reddy?s Laboratories Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Dr. Reddy?s Laboratories Key News
7.6 Jiangsu Hengrui
7.6.1 Jiangsu Hengrui Corporate Summary
7.6.2 Jiangsu Hengrui Business Overview
7.6.3 Jiangsu Hengrui Head and Neck Cancer Therapeutics Major Product Offerings
7.6.4 Jiangsu Hengrui Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Jiangsu Hengrui Key News
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Corporate Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Head and Neck Cancer Therapeutics Major Product Offerings
7.7.4 Teva Pharmaceutical Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Teva Pharmaceutical Key News
7.8 DFG
7.8.1 DFG Corporate Summary
7.8.2 DFG Business Overview
7.8.3 DFG Head and Neck Cancer Therapeutics Major Product Offerings
7.8.4 DFG Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.8.5 DFG Key News
7.9 BioXpress
7.9.1 BioXpress Corporate Summary
7.9.2 BioXpress Business Overview
7.9.3 BioXpress Head and Neck Cancer Therapeutics Major Product Offerings
7.9.4 BioXpress Head and Neck Cancer Therapeutics Revenue in Global Market (2017-2022)
7.9.5 BioXpress Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Head and Neck Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Head and Neck Cancer Therapeutics Market Drivers in Global Market
Table 3. Head and Neck Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Head and Neck Cancer Therapeutics in Global Market
Table 5. Top Head and Neck Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Head and Neck Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Head and Neck Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Head and Neck Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Head and Neck Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Head and Neck Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Head and Neck Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Head and Neck Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Head and Neck Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Head and Neck Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Head and Neck Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Head and Neck Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Head and Neck Cancer Therapeutics Product Offerings
Table 32. Sanofi Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly Corporate Summary
Table 34. Eli Lilly Head and Neck Cancer Therapeutics Product Offerings
Table 35. Eli Lilly Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Head and Neck Cancer Therapeutics Product Offerings
Table 38. Amgen Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Actavis Corporate Summary
Table 40. Actavis Head and Neck Cancer Therapeutics Product Offerings
Table 41. Actavis Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Dr. Reddy?s Laboratories Corporate Summary
Table 43. Dr. Reddy?s Laboratories Head and Neck Cancer Therapeutics Product Offerings
Table 44. Dr. Reddy?s Laboratories Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Jiangsu Hengrui Corporate Summary
Table 46. Jiangsu Hengrui Head and Neck Cancer Therapeutics Product Offerings
Table 47. Jiangsu Hengrui Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceutical Corporate Summary
Table 49. Teva Pharmaceutical Head and Neck Cancer Therapeutics Product Offerings
Table 50. Teva Pharmaceutical Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. DFG Corporate Summary
Table 52. DFG Head and Neck Cancer Therapeutics Product Offerings
Table 53. DFG Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. BioXpress Corporate Summary
Table 55. BioXpress Head and Neck Cancer Therapeutics Product Offerings
Table 56. BioXpress Head and Neck Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Head and Neck Cancer Therapeutics Segment by Type in 2021
Figure 2. Head and Neck Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Head and Neck Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Head and Neck Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Head and Neck Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Head and Neck Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Head and Neck Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Head and Neck Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Actavis Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Dr. Reddy?s Laboratories Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Jiangsu Hengrui Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceutical Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DFG Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BioXpress Head and Neck Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
